StockData

BullFrog AI vs Lisata Therapeutics

BFRG and LSTA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How BFRG and LSTA compare

BullFrog AI and Lisata Therapeutics are about the same size, with market caps of $9.0M and $9.8M.

Lisata Therapeutics scores higher on the StockData Score (6 against 3 for BullFrog AI), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricBFRGLSTA
Size and price
Market cap$9.0M$9.8M
Share price$0.488$1.09
Change, 1 year−51.2%−47.3%
Change, 5 years–−92.6%
Beta (5Y)4.87−1.65
Employees921
StockData Score
Total score36 (better)
Valuation score11
Growth score1 (better)0
Performance score00
Health score15 (better)
Dividend score00
Valuation
P/S–98.2×
P/B1.3×1.2× (better)
FCF yield–−125%
Growth
Revenue growth (TTM)–−90.7%
Profitability
Operating margin–−16427%
Net margin–−14621%
FCF margin–−12323%
Return on equity−131%−99.9% (better)
Return on invested capital–−1645%
Financial health
Debt / equity–0.00
Interest coverage−1105.4×–
Current ratio10.57 (better)3.69
Altman Z-score1.34 (better)−74.72
Piotroski F-score2 (better)1
Dividends and buybacks
Buyback yield−111%−6.0% (better)
Shareholder yield−111%−6.0% (better)
Ownership
Held by institutions7.5%12.1%
Held by insiders13.7%11.6%
Insider net buying, 12 months$71.5K–
Short interest, % of float–0.43%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.